Slc2a1 - OmicsDI

Show results for

Unknown (441)
Transcriptomics (77)
Genomics (69)
Proteomics (26)
Metabolomics (4)
Other (3)
Models (2)

Organisms

Homo sapiens (65)
Mus musculus (24)
Andropogon gerardi (13)
Bacteria (13)
Canis lupus familiaris (13)
Chromatiales bacterium OalgGamma1 (13)
Clavibacter nebraskensis NCPPB 2581 (13)
Cnidaria (13)
Ensifer adhaerens (13)
Fasciola (13)
Human alphaherpesvirus 1 strain 17 (13)
Human alphaherpesvirus 1 strain KOS (13)
Human betaherpesvirus 5 (13)
Human herpesvirus 2 strain 186 (13)
Mesocricetus auratus (13)
Miscanthus x giganteus (13)
Mus musculus (13)
Panicum virgatum (13)
Platyhelminthes (13)
Pseudomonas aeruginosa PA103 (13)
Rattus norvegicus (6)
Bos taurus (2)
Zea mays (1)
Mesocricetus auratus (1)
Drosophila melanogaster (1)
Danio rerio (1)
Cricetulus griseus (1)
Ovis aries (1)
Macaca fascicularis (1)
synthetic construct (1)

Organisms

Homo sapiens (19)
Mus musculus (13)
Cricetulus griseus (1)
Macaca fascicularis (1)
Rattus norvegicus (1)
Ovis aries (1)

Repository

biostudies-arrayexpress (52)
ENA (50)
geo (37)
pride (13)
EGA (8)
MassIVE (8)
MetaboLights (4)
jPOST (3)
GPMDB (2)
iProX (2)
BioModels (1)
EVA (1)
PMR (1)

Tissue

Breast (6)
Cell culture (3)
Fibroblast (3)
Lymph node (2)
T cell (2)
Breast cancer cell line (1)
Epithelial cell (1)
Lung (1)
Neuroblast (1)

Disease

Not Available (2)
Mock infection (1)
Papillary thyroid carcinoma (1)
Lung adenocarcinoma (1)
Lung squamous cell carcinoma (1)

Technology Type

Mass Spectrometry (13)
Shotgun proteomics (13)
Mass spectrometry (4)
SRM/MRM (1)

Instrument Platform

Q Exactive (4)
Illumina HiSeq 2000 (3)
LTQ Orbitrap Velos (3)
Illumina NovaSeq 6000 (2)
Instrument (2)
Liquid Chromatography MS - alternating - reverse phase (2)
Illumina HiSeq 2500 (1)
NextSeq 500 (1)
- (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2015 (16)
2014 (16)
2025 (13)
2023 (12)
2016 (12)
2026 (8)
2024 (7)
2018 (6)
2022 (4)
2020 (4)
2013 (4)
2010 (4)
2006 (4)
2012 (2)
2011 (2)
2009 (2)
2019 (2)
2007 (1)
2021 (1)
2017 (1)

UNIPROT ID/AC

Q969D9 (1)
P13501 (1)
P42768 (1)
Q13480 (1)
P22692 (1)
P53779 (1)
P17936 (1)
Q8WU20 (1)
P10398 (1)
Q9BXX0 (1)
Q9NXG6 (1)
P11487 (1)
P13725 (1)
P08620 (1)
P15036 (1)
Q15746 (1)
P15514 (1)
P21781 (1)
P63261 (1)
P68032 (1)
P60709 (1)
P04004 (1)
Q9Y5S2 (1)
Q5VT25 (1)
P01583 (1)
O75116 (1)
P42830 (1)
P12644 (1)
P14921 (1)
P18146 (1)

CHEBI ID

CHEBI:30413 (1)

Metabolite Name

(s)-Atrolactic acid (1)
D7-S1P (1)
2-Keto-L-gluconate (1)
6-O-phosphonato-D-glucono-1,5-lactone(2-) (1)
Octose 1,8-bisphosphate (1)
Octulose 8-phosphate (1)
S-Ribosylhomocysteine (1)
2,3-Diphosphoglyceric acid (1)
Glyceric acid 1,3-biphosphate (1)
Arachidoyl-CoA (1)
Geranyl-PP (1)
Homo-L-arginine (1)
Stearoyl-CoA (1)
Propionyl-CoA (1)
3-Hydroxy-3-methylglutaryl-CoA (1)
(R)-Lipoic acid (1)
Farnesyl pyrophosphate (1)
2-Ketohexanoic acid (1)
Fluorouracil (1)
4-Aminohippuric acid (1)
Selenomethionine (1)
L-Alanine methyl ester hydrochloride (1)
2,4-Dichlorophenol (1)
Phosphoribosyl pyrophosphate (1)
2-Indolecarboxylic acid (1)
L-Homocysteic acid (1)
Iodotyrosine (1)
Leucylalanine (1)
Hydroxyoctanoic acid (1)
Flavone (1)

IsPrivate

False (1)

Submitter Keywords

Not Peer Reviewed (1)

First Public Date

2026 (9)
2025 (8)
2023 (8)
2024 (7)
2022 (7)
2021 (4)
2018 (3)
2019 (2)
2015 (1)
2014 (1)

Modelling Approach

Boolean model (1)

Study type

Transcription profiling by array (29)
RNA-seq of coding RNA (12)
ChIP-seq (3)
Cell line - High-throughput sequencing (2)
Genotyping by array (1)
Comparative genomic hybridization by array (1)
MicroRNA profiling by array (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of non coding RNA (1)

Release Date

2022 (71)
2025 (66)
2023 (65)
2024 (47)
2021 (44)
2020 (32)
2018 (25)
2015 (21)
2019 (20)
2017 (19)
2016 (17)
2014 (17)
2013 (12)
2026 (8)
2012 (6)
2010 (6)
2011 (5)
2006 (4)
2009 (3)
2008 (3)
2007 (1)
2005 (1)

Lab affiliation

University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (7)
Proteome Dynamics, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, D-13092 Berlin, Germany Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany (2)
Moffitt Cancer Center (1)
Proteome Dynamics MDC in the helmholtz association Berlin-Buch (1)
School of Life Sciences, University of Dundee, Dundee (1)
School of Life Sciences, University of Dundee, Dundee, UK(lab head) (1)

Previous page
1 / 63
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 63
Next page

Sort by:

Relevance

Page size

Glut1 involved in the development of NAFLD

THLE-2 silencing of SLC2A1

ORGANISM(S): Homo sapiens

2012-07-14 | E-MEXP-3310 | biostudies-arrayexpress

Overexpression of SLC2A1, ALDOC and PFKFB4 in the glycolysis pathway drives strong drug resistance in 3D HeLa tumor cell spheroids

The three-dimensional (3D) tumor spheroid model exhibits enhanced fidelity in replicating the tumor microenvironment and demonstrates exceptional resistance to clinical drugs compared to the two-dimensional (2D) monolayer model. In this study, we used multi-omics (transcriptome, proteomics, and me...

ORGANISM(S): Homo Sapiens

2024-06-12 | PXD053058 |

SLC2A1-DT therapy

PRJNA1397219 | ENA

Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndrome.

Not available

S-EPMC5477372 | biostudies-literature

Not available

S-EPMC9657346 | biostudies-literature

miR-455-3p ameliorates pancreatic acinar cell injury by targeting Slc2a1.

Not available

S-EPMC10317017 | biostudies-literature